New pill against hair loss: Results announced
The experimental pill VDPHL01, developed for male-pattern hair loss, yielded positive results in the final‑stage clinical trial. In a six‑month study, participants who took the drug twice daily showed an average increase of 36.4 hairs per square centimeter. The drug must go through the approval process before it can be marketed.
U.S.-based biotechnology company Veradermics tested its experimental drug VDPHL01 on 536 men experiencing mild to moderate hair loss.
According to the company's announced results, after six months the average hair growth per square centimeter was 28.6 in those taking one dose per day and 36.4 in those taking two doses per day. The increase in the placebo group was recorded at 6.6.
The drug was reported to be generally well tolerated. However, swelling and unwanted hair growth in undesired areas were observed more frequently in users than in the placebo group. The company is also studying the treatment in women and expects the results of this study to be announced in the first half of 2027.
Approval is required for the drug to reach the market.
Following the positive results, it was reported that Veradermics shares rose. It was noted that the company's shares have gained more than six times in value since its IPO.
VDPHL01 has not yet received approval for hair loss treatment. While the study results are encouraging, the benefit it offers compared to existing treatments and its long‑term safety still need to be evaluated.
Competition is rising in hair loss treatment
Biotechnology companies are continuing their work to develop more effective treatments for male-pattern hair loss. Hair loss treatments are standing out as a growing market for pharmaceutical companies and investors.
Comments
You must sign in to comment.
Sign InYou Might Also Like
Security crisis at the world's largest crypto exchange
The world's largest cryptocurrency exchange Binance confirmed the cyber‑security incident that affected about $6.3 billion of its assets. In its initial statement, the company said that $2.54 billion of assets had been frozen, and in a subsequent update it reported that the amount had risen to roughly $3 billion.
Human‑induced global warming may have averted a new ice age.
It is being assessed that the global warming caused by fossil‑fuel use may have delayed the expected new glacial period in Earth's natural climate cycle. Studies of plant remains and geological traces from past periods suggest that human activities have influenced the development of glaciers.
Sexual Assault Shock on United Airlines Flight: Passenger Has Been Waiting for a Response for 5 Weeks
The woman who said she was sexually assaulted by the male passenger next to her on the Pittsburgh-Chicago flight in the U.S. said she has not received a response from authorities even after 5 weeks since the incident.
.avif){kind=small}